RedHill Biopharma (RDHL) Operating Margin Growth (5y) (2017 - 2023)
RedHill Biopharma (RDHL) Operating Margin Growth (5y) (2017 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | RedHill Biopharma | 119.32 Mn | 119.32 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 258,619.00 |
| Mar 31, 2023 | -121,680.00 |
| Dec 31, 2022 | -130,975.00 |
| Sep 30, 2022 | -87,644.00 |
| Jun 30, 2022 | -275,318.00 |
| Sep 30, 2020 | -45.91 Mn |
| Jun 30, 2020 | -58.89 Mn |
| Dec 31, 2019 | -48.07 Mn |
| Sep 30, 2019 | 70,252.00 |
| Jun 30, 2019 | -10.21 Mn |
| Mar 31, 2019 | 48,340.00 |
| Dec 31, 2018 | 73,865.00 |
| Sep 30, 2018 | 9.21 Mn |
| Jun 30, 2018 | 6.36 Mn |
| Dec 31, 2017 | 5.36 Mn |
| Sep 30, 2017 | 6.51 Mn |
| Jun 30, 2017 | -3.85 Mn |